Literature DB >> 13199372

Multiple visceral lesions due o phenylbutazone toxicity.

J R NASSIM.   

Abstract

Entities:  

Keywords:  ANALGESICS/injurious effects; OSTEOARTHRITIS/therapy

Mesh：

Substances：

Year:  1954        PMID： 13199372      PMCID： PMC2079766          DOI： 10.1136/bmj.2.4895.1028

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Death from hypersensitivity due to phenylbutazone.

Authors:  D J O'BRIEN; G STOREY
Journal:  Br Med J       Date:  1954-04-03

2.  Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK; B BROWN; E A MANKLE
Journal:  J Am Med Assoc       Date:  1952-06-21

3.  Phenylbutazone (butazolidine) in the treatment of chronic arthritis.

Authors:  L CUDKOWICZ; J H JACOBS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

4.  Fatality due to agranulocytosis following use of phenylbutazone (butazolidin).

Authors:  A D ETESS; A S JACOBSON
Journal:  J Am Med Assoc       Date:  1953-02-21

5.  Agranulocytosis following administration of phenylbutazone (butazolidin).

Authors:  J L STIFEL; J C BURNHEIMER
Journal:  J Am Med Assoc       Date:  1953-02-14

6.  Death following phenylbutazone (butazolidin) therapy: report of a case.

Authors:  D A NATHAN; M L MEITUS; L CAPLAND; M LEV
Journal:  Ann Intern Med       Date:  1953-11       Impact factor: 25.391
  6 in total
  2 in total

1.  Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

Authors:  J M MACCARTHY; R T JACKSON
Journal:  Br Med J       Date:  1955-07-23

2.  Granulomas and cholestatic--hepatocellular injury associated with phenylbutazone. Report of two cases.

Authors:  K G Ishak; J P Kirchner; J K Dhar
Journal:  Am J Dig Dis       Date:  1977-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.